Insperity (NSP) Competitors $45.08 -14.50 (-24.34%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$45.11 +0.03 (+0.06%) As of 08/1/2025 06:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock NSP vs. CCRN, RHI, KFY, ASGN, MAN, BBSI, HSII, KFRC, KELYA, and TBIShould you be buying Insperity stock or one of its competitors? The main competitors of Insperity include Cross Country Healthcare (CCRN), Robert Half (RHI), Korn/Ferry International (KFY), ASGN (ASGN), ManpowerGroup (MAN), Barrett Business Services (BBSI), Heidrick & Struggles International (HSII), Kforce (KFRC), Kelly Services (KELYA), and TrueBlue (TBI). Insperity vs. Its Competitors Cross Country Healthcare Robert Half Korn/Ferry International ASGN ManpowerGroup Barrett Business Services Heidrick & Struggles International Kforce Kelly Services TrueBlue Cross Country Healthcare (NASDAQ:CCRN) and Insperity (NYSE:NSP) are both small-cap business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, risk, earnings, institutional ownership, analyst recommendations and valuation. Which has stronger valuation & earnings, CCRN or NSP? Insperity has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Insperity, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCross Country Healthcare$1.26B0.34-$14.56M-$0.53-24.60Insperity$6.64B0.26$91M$1.6826.83 Do analysts recommend CCRN or NSP? Cross Country Healthcare currently has a consensus target price of $17.93, indicating a potential upside of 37.50%. Insperity has a consensus target price of $80.00, indicating a potential upside of 77.46%. Given Insperity's higher probable upside, analysts clearly believe Insperity is more favorable than Cross Country Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cross Country Healthcare 0 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Insperity 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67 Is CCRN or NSP more profitable? Insperity has a net margin of 0.95% compared to Cross Country Healthcare's net margin of -1.41%. Insperity's return on equity of 52.17% beat Cross Country Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Cross Country Healthcare-1.41% 2.56% 1.84% Insperity 0.95%52.17%2.87% Does the media refer more to CCRN or NSP? In the previous week, Insperity had 20 more articles in the media than Cross Country Healthcare. MarketBeat recorded 28 mentions for Insperity and 8 mentions for Cross Country Healthcare. Cross Country Healthcare's average media sentiment score of 0.89 beat Insperity's score of 0.40 indicating that Cross Country Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cross Country Healthcare 4 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Insperity 3 Very Positive mention(s) 6 Positive mention(s) 14 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility and risk, CCRN or NSP? Cross Country Healthcare has a beta of 0.36, indicating that its stock price is 64% less volatile than the S&P 500. Comparatively, Insperity has a beta of 0.47, indicating that its stock price is 53% less volatile than the S&P 500. Do institutionals and insiders have more ownership in CCRN or NSP? 96.0% of Cross Country Healthcare shares are owned by institutional investors. Comparatively, 93.4% of Insperity shares are owned by institutional investors. 4.9% of Cross Country Healthcare shares are owned by insiders. Comparatively, 5.3% of Insperity shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. SummaryInsperity beats Cross Country Healthcare on 11 of the 15 factors compared between the two stocks. Get Insperity News Delivered to You Automatically Sign up to receive the latest news and ratings for NSP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NSP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NSP vs. The Competition Export to ExcelMetricInsperityStaffing IndustryBusiness SectorNYSE ExchangeMarket Cap$1.70B$1.51B$14.77B$20.68BDividend Yield3.99%3.32%2.81%3.67%P/E Ratio26.8329.1624.0529.07Price / Sales0.264.0168.4066.27Price / Cash16.508.1926.9422.84Price / Book17.413.285.074.43Net Income$91M$30.69M$195.86M$994.22M7 Day Performance-25.21%-8.68%-4.24%-3.35%1 Month Performance-26.87%-6.58%-1.10%-2.06%1 Year Performance-52.86%-24.05%28.98%10.15% Insperity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NSPInsperity4.5794 of 5 stars$45.08-24.3%$80.00+77.5%-53.7%$1.70B$6.64B26.834,500Trending NewsEarnings ReportGap DownHigh Trading VolumeCCRNCross Country Healthcare3.5875 of 5 stars$13.36+4.5%$17.93+34.2%-25.7%$418.97M$1.34B-25.218,205News CoverageRHIRobert Half4.7341 of 5 stars$41.83-0.1%$48.71+16.5%-43.7%$4.28B$5.80B20.9314,700KFYKorn/Ferry International4.3022 of 5 stars$73.16-1.1%$81.00+10.7%-3.9%$3.82B$2.76B15.109,253ASGNASGN3.8927 of 5 stars$48.27-0.3%$63.67+31.9%-47.3%$2.12B$4.10B13.753,200Analyst UpgradeMANManpowerGroup4.4045 of 5 stars$42.18-2.5%$48.20+14.3%-47.2%$2.00B$17.85B12.2526,700Positive NewsBBSIBarrett Business Services4.2749 of 5 stars$43.70+0.2%$45.00+3.0%+20.1%$1.12B$1.14B22.413,658News CoveragePositive NewsUpcoming EarningsHSIIHeidrick & Struggles International2.638 of 5 stars$45.63-1.1%$49.00+7.4%+10.1%$951.65M$1.12B130.382,201News CoverageUpcoming EarningsKFRCKforce4.198 of 5 stars$42.73-0.5%$53.67+25.6%-49.3%$796.08M$1.38B15.9412,000Trending NewsEarnings ReportDividend AnnouncementAnalyst ForecastAnalyst RevisionKELYAKelly Services4.6345 of 5 stars$12.71+1.2%$25.00+96.7%-46.5%$438.19M$4.33B5.904,200News CoveragePositive NewsUpcoming EarningsTBITrueBlue4.0223 of 5 stars$7.05-0.7%$10.00+41.9%-42.3%$212.04M$1.57B0.004,200Upcoming EarningsGap Down Related Companies and Tools Related Companies CCRN Competitors RHI Competitors KFY Competitors ASGN Competitors MAN Competitors BBSI Competitors HSII Competitors KFRC Competitors KELYA Competitors TBI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:NSP) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Insperity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Insperity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
